We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+12.8%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.21B
AUM Growth
-$296M
(-8.4%)
Cap. Flow
-$592M
Cap. Flow
% of AUM
-18.42%
Top 10 Holdings %
Top 10 Hldgs %
43.24%
Holding
304
New
89
Increased
36
Reduced
82
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtaiBeckley Inc
ATAI
|
+$25.3M |
| 2 |
Agilon Health
AGL
|
+$13.5M |
| 3 |
Eli Lilly
LLY
|
+$13.2M |
| 4 |
Privia Health
PRVA
|
+$12.8M |
| 5 |
Lantheus
LNTH
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$23.9M |
| 2 |
Vericel Corp
VCEL
|
+$20.8M |
| 3 |
Align Technology
ALGN
|
+$19M |
| 4 |
SI-BONE Inc
SIBN
|
+$17.5M |
| 5 |
STAAR Surgical
STAA
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.64% |
| 2 | Industrials | 1.41% |
| 3 | Materials | 0.54% |
| 4 | Financials | 0.48% |
| 5 | Consumer Staples | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
CALL
Korro Bio
KRRO
$195M
| – | – |
-2,000
| Closed | -$950K |
|
|
252
Korro Bio
KRRO
$195M
| – | – |
-2,000
| Closed | -$950K |
|
|
253
PUT
Korro Bio
KRRO
$195M
| – | – |
-5,000
| Closed | -$2.38M |
|
|
LVTX
254
DELISTED
LAVA Therapeutics
LVTX
| – | – |
-54,000
| Closed | -$820K |
|
255
PUT
McKesson
MCK
$103B
| – | – |
-225,000
| Closed | -$43.9M |
|
256
CALL
MacroGenics
MGNX
$256M
| – | – |
-175,000
| Closed | -$5.57M |
|
|
257
MacroGenics
MGNX
$256M
| – | – |
-68,792
| Closed | -$2.19M |
|
258
CALL
Merck
MRK
$328B
| – | – |
-104,800
| Closed | -$7.71M |
|
259
Moderna
MRNA
$25.5B
| – | – |
-26,791
| Closed | -$3.51M |
|
|
260
PUT
Moderna
MRNA
$25.5B
| – | – |
-50,600
| Closed | -$6.63M |
|
261
Maravai LifeSciences
MRVI
$876M
| – | – |
-236,350
| Closed | -$8.42M |
|
262
Nkarta
NKTX
$168M
| – | – |
-7,919
| Closed | -$261K |
|
263
PUT
Nano X Imaging
NNOX
$75.2M
| – | – |
-100,000
| Closed | -$4.14M |
|
264
Envista
NVST
$4.63B
| – | – |
-283,176
| Closed | -$11.6M |
|
265
PUT
VanEck Pharmaceutical ETF
PPH
$990M
| – | – |
-550,000
| Closed | -$38M |
|
266
Quantum-Si Incorporated
QSI
$184M
| – | – |
-115,477
| Closed | -$1.38M |
|
|
267
SI-BONE Inc
SIBN
$841M
| – | – |
-550,104
| Closed | -$17.5M |
|
268
CALL
Solid Biosciences
SLDB
$976M
| – | – |
-6,667
| Closed | -$553K |
|
269
PUT
Teleflex
TFX
$5.91B
| – | – |
-20,000
| Closed | -$8.31M |
|
270
PUT
Transmedics
TMDX
$3.04B
| – | – |
-150,000
| Closed | -$6.22M |
|
271
PUT
Tandem Diabetes Care
TNDM
$1.59B
| – | – |
-70,800
| Closed | -$6.25M |
|
272
PUT
UnitedHealth
UNH
$363B
| – | – |
-75,000
| Closed | -$27.9M |
|
|
273
Vericel Corp
VCEL
$2.29B
| – | – |
-374,435
| Closed | -$20.8M |
|
274
Vertex Pharmaceuticals
VRTX
$134B
| – | – |
-10,243
| Closed | -$2.2M |
|
|
WGSWW
275
DELISTED
GeneDx Holdings Warrant
WGSWW
| – | – |
-101,416
| Closed | -$525K |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q2 2021 Portfolio in Review
As of Q2 2021, Pura Vida Investments held 304 positions worth $3.21B, down 8.4% from $3.51B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Pura Vida Investments withdrew a net $592M in Q2 2021, closing 88 positions and reducing 82 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $23.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.
Against the trend, Pura Vida Investments opened a new position in AtaiBeckley Inc worth $23.2M.
- Pura Vida Investments's largest Q2 2021 buy was AtaiBeckley Inc: 1,371,824 shares worth $23.2M.
- Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q2 2021, an estimated $9.15M increase.
- Pura Vida Investments's biggest Q2 2021 reduction was STAAR Surgical, cutting an estimated $14.6M.
- Pura Vida Investments fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $23.9M.
- Pura Vida Investments's ten largest holdings make up 43% of its $3.21B portfolio in Q2 2021.
- Pura Vida Investments opened 89 new positions and closed 88 in Q2 2021.
- Pura Vida Investments's portfolio value fell 8.4% quarter-over-quarter to $3.21B.
Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.